MicroRNAs: Opening a new vein in angiogenesis research

Science Signaling

Volumn 2, Issue 52, 2009, Pages

  Fish, Jason E ^a   Srivastava, Deepak ^b  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SIGNAL PEPTIDE;

ANGIOGENESIS; DIABETIC RETINOPATHY; GENE EXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; ANIMAL; BIOLOGICAL MODEL; BONE MARROW; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); REGENERATION; REVIEW;

ANIMALS; BONE MARROW; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; REGENERATION; SIGNAL TRANSDUCTION;

EID: 62349138052     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.252pe1     Document Type: Short Survey

References (42)

1. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney, M. Magner, J. M. Isner, T. Asahara, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438 (1999). (Pubitemid 29180584) (Pubitemid 29180584)
2. P. Carmeliet, VEGF as a key mediator of angiogenesis in cancer. Oncology 69 (suppl. 3), 4-10 (2005).
3. M. Graupera, J. Guillermet-Guibert, L. C. Foukas, L. K. Phng, R. J. Cain, A. Salpekar, W. Pearce, S. Meek, J. Millan, P. R. Cutillas, A. J. H. Smith, A. J. Ridley, C. Ruhrberg, H. Gerhardt, B. Vanhaesebroeck, Angiogenesis selectively requires the p110a isoform of PI3K to control endothelial cell migration. Nature 453, 662-666 (2008).
4. M. Simons, Integrative signaling in angiogenesis. Mol. Cell. Biochem. 264, 99-102 (2004).
5. R. S. Kerbel, Tumor angiogenesis. N. Engl. J. Med. 358, 2039-2049 (2008).
6. C. A. Jones, N. R. London, H. Chen, K. W. Park, D. Sauvaget, R. A. Stockton, J. D. Wythe, W. Suh, F. Larrieu-Lahargue, Y. S. Mukouyama, P. Lindblom, P. Seth, A. Frias, N. Nishiya, M. H. Ginsberg, H. Gerhardt, K. Zhang, D. Y. Li, Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 14, 448-453 (2008).
7. C. K. Williams, J. L. Li, M. Murga, A. L. Harris, G. Tosato, Up-regulation of the Notch ligand Deltalike 4 inhibits VEGF-induced endothelial cell function. Blood 107, 931-939 (2006).
8. Y. Zhao, D. Srivastava, A developmental view of microRNA function. Trends Biochem. Sci. 32, 189-197 (2007).
9. Z. Mourelatos, Small RNAs: The seeds of silence. Nature 455, 44-45 (2008).
10. W. Filipowicz, S. N. Bhattacharyya, N. Sonenberg, Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008).
11. S. Vasudevan, Y. Tong, J. A. Steitz, Switching from repression to activation: MicroRNAs can upregulate translation. Science 318, 1931-1934 (2007); published online 29 November 2007 (10.1126/science.1149460).
12. J. I. Henke, D. Goergen, J. Zheng, Y. Song, C. G. Schüttler, C. Fehr, C. Jünemann, M. Niepmann, MicroRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 27, 3300-3310 (2008).
13. J. E. Fish, M. M. Santoro, S. U. Morton, S. Yu, R. F. Yeh, J. D. Wythe, K. N. Ivey, B. G. Bruneau, D. Y. Stainier, D. Srivastava, miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 15, 272-284 (2008).
14. S. Wang, A. B. Aurora, B. A. Johnson, X. Qi, J. McAnally, J. A. Hill, J. A. Richardson, R. Bassel- Duby, E. N. Olson, The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev. Cell 15, 261-271 (2008).
15. F. Kuhnert, M. R. Mancuso, J. Hampton, K. Stankunas, T. Asano, C. Z. Chen, C. J. Kuo, Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135, 3989-3993 (2008).
16. Y. Suarez, C. Fernandez-Hernando, J. S. Pober, W. C. Sessa, Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 100, 1164-1173 (2007).
17. L. Poliseno, A. Tuccoli, L. Mariani, M. Evangelista, L. Citti, K. Woods, A. Mercatanti, S. Hammond, G. Rainaldi, MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108, 3068-3071 (2006).
18. A. Kuehbacher, C. Urbich, A. M. Zeiher, S. Dimmeler, Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101, 59-68 (2007).
19. T. Wurdinger, B. A. Tannous, O. Saydam, J. Skog, S. Grau, J. Soutschek, R. Weissleder, X. O. Breakefield, A. M. Krichevsky, miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14, 382-393 (2008).
20. Y. Suarez, C. Fernandez-Hernando, J. Yu, S. A. Gerber, K. D. Harrison, J. S. Pober, M. L. Iruela- Arispe, M. Merkenschlager, W. C. Sessa, Dicerdependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 105, 14082-14087 (2008).
21. Y. Chen, D. H. Gorski, Regulation of angiogenesis through a microRNA (miR-130a) that downregulates antiangiogenic homeobox genes GAX and HOXA5. Blood 111, 1217-1226 (2008).
22. P. Fasanaro, Y. D'Alessandra, V. Di Stefano, R. Melchionna, S. Romani, G. Pompilio, M. C. Capogrossi, F. Martelli, MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883 (2008).
23. W. J. Yang, D. D. Yang, S. Na, G. E. Sandusky, Q. Zhang, G. Zhao, Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 280, 9330-9335 (2005).
24. G. Hutvágner, J. McLachlan, A. E. Pasquinelli, E. Bálint, T. Tuschl, P. D. Zamore, A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834-838 (2001).
25. E. Bernstein, S. Y. Kim, M. A. Carmell, E. P. Murchison, H. Alcorn, M. Z. Li, A. A. Mills, S. J. Elledge, K. V. Anderson, G. J. Hannon, Dicer is essential for mouse development. Nat. Genet. 35, 215-217 (2003).
26. M. Otsuka, M. Zheng, M. Hayashi, J. D. Lee, O. Yoshino, S. Lin, J. Han, Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J. Clin. Invest. 118, 1944-1954 (2008).
27. S. Shilo, S. Roy, S. Khanna, C. K. Sen, Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 471-477 (2008).
28. T. Wakioka, A. Sasaki, R. Kato, T. Shouda, A. Matsumoto, K. Miyoshi, M. Tsuneoka, S. Komiya, R. Baron, A. Yoshimura, Spred is a Sproutyrelated suppressor of Ras signalling. Nature 412, 647-651 (2001).
29. K. Ueki, D. A. Fruman, C. M. Yballe, M. Fasshauer, J. Klein, T. Asano, L. C. Cantley, C. R. Kahn, Positive and negative roles of p85 α and p85 β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J. Biol. Chem. 278, 48453-48466 (2003).
30. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. J. Lee, J. O. Lotvall, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
31. G. A. Calin, C. M. Croce, MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006).
32. M. Dews, A. Homayouni, D. Yu, D. Murphy, C. Sevignani, E. Wentzel, E. E. Furth, W. M. Lee, G. H. Enders, J. T. Mendell, A. Thomas-Tikhonenko, Augmentation of tumor angiogenesis by a Mycactivated microRNA cluster. Nat. Genet. 38, 1060-1065 (2006).
33. D. Y. Lee, Z. Deng, C. H. Wang, B. B. Yang, MicroRNA- 378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. U.S.A. 104, 20350-20355 (2007).
34. K. J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H. S. Phillips, N. Ferrara, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844 (1993).
35. Z. Hua, Q. Lv, W. Ye, C. K. Wong, G. Cai, D. Gu, Y. Ji, C. Zhao, J. Wang, B. B. Yang, Y. Zhang, MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1, e116 (2006).
36. M. Garofalo, G. Condorelli, C. M. Croce, MicroRNAs in diseases and drug response. Curr. Opin. Pharmacol. 8, 661-667 (2008).
37. J. Elmen, M. Lindow, S. Schutz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjarn, H. F. Hansen, U. Berger, S. Gullans, P. Kearney, P. Sarnow, E. M. Straarup, S. Kauppinen, LNAmediated microRNA silencing in non-human primates. Nature 452, 896-899 (2008).
38. J. Krutzfeldt, N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, M. Stoffel, Silencing of microRNAs in vivo with "antagomirs. " Nature 438, 685-689 (2005).
39. A. Rodriguez, S. Griffiths-Jones, J. L. Ashurst, A. Bradley, Identification of mammalian microRNA host genes and transcription units. Genome Res. 14, 1902-1910 (2004).
40. L. Campagnolo, A. Leahy, S. Chitnis, S. Koschnick, M. J. Fitch, J. T. Fallon, D. Loskutoff, M. B. Taubman, H. Stuhlmann, EGFL7 is a chemoattractant for endothelial cells and is upregulated in angiogenesis and arterial injury. Am. J. Pathol. 167, 275-284 (2005).
41. L. H. Parker, M. Schmidt, S. W. Jin, A. M. Gray, D. Beis, T. Pham, G. Frantz, S. Palmieri, K. Hillan, D. Y. Stainier, F. J. De Sauvage, W. Ye, The endothelial- cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428, 754-758 (2004).
42. We thank G. Howard (J. David Gladstone Institutes), J. Wythe (Gladstone Institute of Cardiovascular Disease), and P. Marsden (University of Toronto) for critically reading the manuscript and K. Cordes (Gladstone Institute of Cardiovascular Disease) for advice on figure preparation. Supported by a Canadian Institute of Health Research Postdoctoral Fellowship and a Lynda and Stewart Resnick Fellowship (J.E.F.) and by grants from the National Heart, Lung, and Blood Institute; the American Heart Association; and the California Institute of Regenerative Medicine (D.S.).